skip to main |
skip to sidebar
6:34 AM
Jalal HB
No comments
A large number of people around find it very difficult to sleep - or in other words suffer from Insomnia. Even sleeping for one hour is not possible for some despite taking tons of sleep inducing medicines.
But there seems to be a big thaw in the reserach work to cure isnomnia as neurologists at Oxford University think they have discovered the switch in the brain that tells our bodies when to go to sleep.
Described as a ‘homeostat’ which can tell when someone has been awake for too many hours, the mechanism fires when the body is tired.
Professor Gero Miesenböck, whose team conducted the research, said: ‘When you’re tired, these neurons in the brain shout loud and they send you to sleep.’
The researchers demonstrated the theory on fruit flies, removing the switch to create insomniac insects.
Read more about it at: Mail Online
If you like Imposing Headlines, please follow us on Facebook
10:34 AM
Jalal HB
No comments
For the elderly, osteoporosis is a deadly disease which leaves bones so brittle that even a small fall can result into a bone fracture. Every month, 1,150 die prematurely as a result of a hip fractures and half of patients do not regain their independence. At least 120,000 people a year suffer spinal fractures.
However, now there is good news.
Two drugs currently used to treat osteoporosis could produce better results if used in tandem, researchers say.
Using a combination of the drugs, already available on the NHS, resulted in an increase in bone density of up to 5 per cent in just a year, they found.
Most currently available osteoporosis drugs, including denosumab, stop the action of cells that break down bone during the normal process of bone formation. In contrast, teriparatide – also known as Forsteo – stimulates the creation of new bone.
Now a latest trial found women given combination therapy had greater improved bone density than those receiving denosumab alone.
In the study, a team from Massachusetts General Hospital in Boston randomly assigned 94 post-menopausal women with osteoporosis to treatment with either teriparatide taken as a daily pill, or a six-monthly jab with denosumab, or both drugs for 12 months.
The researchers measured density changes in lumbar spine, hip bone, and femoral neck using low-dose x-rays and bone biomarkers.
6:34 AM
Jalal HB
